Sonoma Pharmaceuticals, Inc. New Standards Disclosure
Recent Accounting Standards
The Company has evaluated all the recent accounting standards and determined that none are material to it.
Want the next Sonoma Pharmaceuticals, Inc. new standards disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Sonoma Pharmaceuticals, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | Jun 16, 2026 | Showing above |
| 2025 | Jun 17, 2025 | |
| 2024 | Jun 17, 2024 | |
| 2023 | Jun 21, 2023 | |
| 2022 | Jul 13, 2022 | |
| 2021 | Jul 14, 2021 | |
| 2020 | Jul 10, 2020 | |
| 2019 | Jul 1, 2019 | |
| 2018 | Jun 26, 2018 | |
| 2017 | Jun 28, 2017 | |
| 2016 | Jun 21, 2016 | |
About New Standards Disclosures
New accounting standards disclosures describe recently adopted pronouncements and those not yet effective, along with management's assessment of their expected impact. This section provides an early warning system for upcoming changes to how a company reports its financial results, often years before the new rules take effect.
Key signals: when management describes a not-yet-adopted standard's impact as "material" or "still being evaluated," it signals potential significant changes to reported metrics upon adoption. Watch for standards that affect a company's core operations — for example, revenue recognition changes for software companies or lease accounting changes for retailers with large store footprints. The transition method chosen (full retrospective versus modified retrospective) affects comparability with prior periods. Companies that delay adoption to the latest permitted date may be struggling with implementation complexity. Compare the disclosed impact assessments against peers in the same industry to gauge whether management's expectations are reasonable.